We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
JAMA Patient Page |

Myasthenia Gravis FREE

Janet M. Torpy, MD, Writer; Tiffany J. Glass, MA, Illustrator; Richard M. Glass, MD, Editor
JAMA. 2005;293(15):1940. doi:10.1001/jama.293.15.1940.
Text Size: A A A
Published online

Myasthenia gravis is an autoimmune disease that gradually causes muscles to lose their strength and function. Autoimmune diseases are caused by the body making substances called antibodies that attack a person's own tissues. In myasthenia gravis, these antibodies are made against receptors in the neuromuscular junction (the area where nerve transmission makes a muscle do its work). Myasthenia gravis affects individuals differently, and each person may present with weakness in different sets of muscles. The April 20, 2005, issue of JAMA includes an article about diagnosing myasthenia gravis.


  • Muscle weakness

  • Double vision

  • Weak eyelids

  • Difficulty speaking or smiling

  • Difficulty chewing and swallowing

Muscle weakness related to myasthenia gravis usually occurs after the muscle group is used and lessens if the muscle group has some rest. This is called fatigable weakness and is an important characteristic for the diagnosis of myasthenia gravis.


Your doctor will take a medical history, asking especially about the type of muscle weakness, what makes it better, and what makes it worse. A physical examination may reveal weakness of the extremities, the eye muscles, or difficulty in facial expression. Several tests may be used to help diagnose myasthenia gravis:

  • Ice pack or rest test (simple procedures that temporarily improve eyelid drooping)

  • Edrophonium test (a medication given through an intravenous line, temporarily improving strength in patients with myasthenia gravis)

  • Blood tests may show antibodies to the receptor at the neuromuscular junction

  • Nerve conduction studies may show fatigable weakness in individual muscle groups


Symptoms of myasthenia gravis can usually be improved with medications that increase the amount of acetylcholine (a neurotransmitter) at the neuromuscular junction. Treatments involving the immune system include injections of intravenous immunoglobulin, immunosuppressive medications, and plasmapheresis (removal of antibodies from the blood). If an individual's myasthenia is found to be related to abnormalities in the thymus gland located at the base of the neck underneath the breastbone (sternum), a thymectomy (surgical removal of the thymus gland) may help to improve the symptoms. When respiratory (breathing) muscles fail, this is called a myasthenic crisis. This type of respiratory failure is an emergency. It may require intensive care and use of a ventilator to assist breathing. Some factors leading to a myasthenic crisis include infection, fever, medication effects, or even stress.



To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com.

Sources: National Institute of Neurological Disorders and Stroke; American Academy of Neurology; Myasthenia Gravis Foundation of America

The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. Any other print or online reproduction is subject to AMA approval. To purchase bulk reprints, call 718/946-7424.




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Myasthenia Gravis

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Make the Diagnosis: Myasthenia Gravis